Alnylam CEO John Maraganore is a big fan of five-year plans, and with JPM21 kicking off this week, he revealed his company’s newest ambitious goal — become a “top 5 biotech” by 2025.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,